FDA全球物质注册数据库(FDA Global Substance Registration System)
物质名称IVICENTAMAB
异名/同义词IMMUNOGLOBULIN G1 (408-LEUCINE,433-GLYCINE,DE-450-LYSINE), ANTI-(HUMAN CD37 ANTIGEN) (HUMAN-ORYCTOLAGUS CUNICULUS BIPARATOPIC MONOCLONAL 3009-016-H5L2 .GAMMA.1-CHAIN), DISULFIDE WITH (90-SERINE) HUMAN-ORYCTOLAGUS CUNICULUS BIPARATOPIC MONOCLONAL 3009-016-H5L2 .KAPPA.-CHAIN, (229->228'),(232->231')-BIS(DISULFIDE) WITH IMMUNOGLOBULIN G1 (411-ARGININE,432-GLYCINE,DE-449-LYSINE) ANTI-(HUMAN CD37 ANTIGEN) (HUMAN-ORYCTOLAGUS CUNICULUS BIPARATOPIC MONOCLONAL 3009-010-H5L2 .GAMMA.1-CHAIN) DISULFIDE WITH HUMAN-ORYCTOLAGUS CUNICULUS BIPARATOPIC MONOCLONAL 3009-010-H5L2 .KAPPA.-CHAIN
IVICENTAMAB
IVICENTAMAB [INN]
DUOHEXABODY-CD37
GEN 3009 [WHO-DD]
CAS登记号2364496-42-2
物质唯一标识(Unique Ingredient Identifier)4O7JS64H45
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
  • 药品国际非专利名称数据库
  • 世界卫生组织药物词典
扩展资源
©2006-2026 Drugfuture->FDA Global Substance Registration System